首页> 美国卫生研究院文献>Cancer Management and Research >Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study

【2h】

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study

机译：新辅助化疗后接受食管切除术的局部晚期食管鳞状细胞癌患者的长期生存：一项队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeThe role of neoadjuvant chemotherapy and subsequent adjuvant therapy in the treatment of patients with locally advanced esophageal squamous cell carcinomas (ESCC) is not well established.

机译：目的新辅助化疗和后续辅助治疗在局部晚期食管鳞状细胞癌（ESCC）患者中的作用尚不明确。

著录项

期刊名称 Cancer Management and Research
作者
Zekai Huang; Shaolei Li; Xin Yang; Fangliang Lu; Miao Huang; Shanyuan Zhang; Ying Xiong; Panpan Zhang; Jiahui Si; Yuanyuan Ma; Yue Yang;
展开▼
作者单位

展开▼
年(卷),期 2019(11),-1
年度 2019
页码 1299–1308
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
locally advanced esophageal squamous cell carcinoma neoadjuvant chemotherapy surgery adjuvant therapy;

机译：局部晚期食管鳞状细胞癌;新辅助化疗;手术;辅助治疗;

相似文献

外文文献
中文文献
专利

1. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT 3-4a N 0-1 M 0 ) (NCT03001596) [J] . Han Tang, Lijie Tan, Yaxing Shen, BMC Cancer . 2017,第1期

机译：CMISG1701：一项多中心前瞻性随机III期临床试验，比较了局部晚期可切除食管鳞状细胞癌（cT 3-4a N 0-1 M 0）的患者中新辅助放化疗与新辅助化疗后再进行微创食管切除术（NCT03001596）
2. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT 3-4a N 0-1 M 0 ) (NCT03001596) [J] . Han Tang, Lijie Tan, Yaxing Shen, BMC Cancer . 2017,第1期

机译：CMISG1701：一项多中心前瞻性随机III期临床试验，比较了局部晚期可切除食管鳞状细胞癌（cT 3-4a N 0-1 M 0）的患者中新辅助放化疗与新辅助化疗后再进行微创食管切除术（NCT03001596）
3. REG I Expression Predicts Long-term Survival among Locally Advanced Thoracic Squamous Cell Esophageal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Esophagectomy [J] . Satoru Motoyama MD, Toshihiro Sugiyama MD, Yasuharu Ueno MD, Annals of Surgical Oncology . 2006,第12期

机译：REG I表达预测接受新辅助放化疗联合食管切除术治疗的局部晚期胸鳞癌食管癌患者的长期生存
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Identification of Novel Candidate Tumor Suppressor Genes at 11q and 15q for Esophageal Squamous Cell Carcinoma and Nasopharyngeal Carcinoma via Integrative Cancer Epigenetics and Genomics. [D] . Li, Jisheng. 2010

机译：通过综合癌症表观遗传学和基因组学鉴定食管鳞状细胞癌和鼻咽癌的11q和15q新型候选肿瘤抑制基因。
6. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596) [O] . Han Tang, Lijie Tan, Yaxing Shen, 2017

机译：CMISG1701：一项多中心前瞻性随机III期临床试验比较了局部晚期可切除食管鳞状细胞癌（cT3-4aN0-1M0）患者中新辅助放化疗与新辅助化疗后再进行微创食管切除术（NCT03001596）
7. >Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study [O] . Zekai Huang, Shaolei Li, Xin Yang, 2019

机译：>患者的长期存活患者局部晚期食管鳞状细胞癌接受Neoadjuvant化疗后的食管切除术：群组研究

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study

摘要

著录项

相似文献

相关主题

期刊订阅